MELD 3.0 is a more accurate predictor of mortality in decompensated cirrhosis than MELD and MELD-Na
##plugins.themes.academic_pro.article.main##
Abstract
Backgroud and aim: Prognostic scores guide organ allocation in cirrhosis.We assessed the performance of MELD, MELD-Na, and MELD 3.0 for predicting mortality in decompensated Tunisian cirrhotic patients
Methods: We conducted a retrospective study including decompensated cirrhosis patients in a Tunisian gastroenterology department.
Results: 152 patients were enrolled (mean age 61 years; viral etiology 65.1%). Mean MELD-Na and MELD 3.0 were 17.7 and 19.4. Mean follow-up: 17.1 months. Decompensation rate: 33.6%; 3-month mortality: 18.4%. For 3-month mortality, AUROCs were 0.786 (MELD), 0.841 (MELD-Na), and 0.850 (MELD 3.0). MELD 3.0 cut-off of 24 yielded sensitivity 68%,
specificity 88% (p=0.04 for association with mortality).
Conclusion: MELD 3.0 outperformed MELD and MELD-Na in predicting mortality. A MELD 3.0 score ≥24 identifies patients who should be prioritized
on the transplant waiting list.
Keywords:
Cirrhosis, Prognosis, mortality, Liver transplanation##plugins.themes.academic_pro.article.details##
This work is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License.
References
- Polyak A, Kuo A, Sundaram V. Evolution of liver transplant organ allocation policy: Current limitations and future directions. World J
- Hepatol. 27 août 2021;13(8):830 9
- Nagai S.Chau L.C.Schilke R.E.et al.Effects of allocating livers for transplantation based on Model for End-Stage Liver Disease-
- Sodium scores on patient outcomes.Gastroenterology. 2018; 155: 1451-1462
- Kim WR, Mannalithara A, Heimbach JK, Kamath PS, Asrani SK, Biggins SW, Wood NL et al. MELD 3.0: The Model for End-stage Liver
- Disease Updated for the Modern Era. Gastroenterology, 2021.
- Sepanlou SG, Safiri S, Bisignano C, Ikuta KS, Merat S, Saberifiroozi M, et al. The global, regional, and national burden of cirrhosis by cause
- in 195 countries and territories, 1990–2017: a systematic analysis for the global burden of disease study 2017. Lancet Gastroenterol
- Hepatol. 2020 Mar;5(3):245-66.
- Karoui S, Hamzaoui S, Sahli F, Matri S, Boubaker J, Filali F. Mortalité au cours des cirrhoses: prévalence, causes et facteurs prédictifs.
- Tunis Med 2002;80:21-5
- Conn HO. A peek at the child-turcotte classification. Hepatology. 1981 Nov;1(6):673-6.
- Boursier J, Cesbron E, Tropet AL, Pilette C. Comparison and improvement of MELD and child-pugh score accuracies for the
- prediction of 6-month
- Schiff ER, Maddrey WC, Sorrell MF. Schiff’s Diseases of the Liver. John Wiley & Sons; 2011
- Godfrey EL, Malik TH, Lai JC, et al. The decreasing predictive power of MELD in an era of changing etiology of liver disease. Am J
- Transplant 2019;19:3299–3307.
- Biggins SW, Rodriguez HJ, Bacchetti P, Bass NM, Roberts JP, Terrault NA. Serum sodium predicts mortality in patients listed for liver
- transplantation. Hepatology. janv 2005;41(1):32-9.
- Wu SL, Zheng YX, Tian ZW, Chen MS, Tan HZ. Scoring systems for prediction of mortality in decompensated liver cirrhosis:
- A meta-analysis of test accuracy. World J Clin Cases. 6 déc 2018;6(15):995-1006.
- Locke JE, Shelton BA, Olthoff KM, Pomfret EA, Forde KA, Sawinski D, Gray M et al. Quantifying Sex- Based Disparities in Liver Allocation.
- JAMA Surg, 2020, 155:e201129.
- Allen AM, Heimbach JK, Larson JJ, Mara KC, Kim WR, Kamath PS, Therneau TM. Reduced Access to Liver Transplantation in Women:
- Role of Height, MELD Exception Scores, and Renal Function Underestimation. Transplantation, 2018, 102:1710–1716.
- Kim WR, Mannalithara A, Heimbach JK, Kamath PS, Asrani SK, Biggins SWand al. MELD 3.0: The Model for End-Stage Liver Disease
- Updated for the Modern Era. Gastroenterology. 2021;161(6):1887- 1895.e4.